Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

Carey MA, Bradbury JA, Rebolloso YD, Graves JP, Zeldin DC, Germolec DR.

PLoS One. 2010 Jul 15;5(7):e11610. doi: 10.1371/journal.pone.0011610.

2.

Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection.

Carey MA, Bradbury JA, Seubert JM, Langenbach R, Zeldin DC, Germolec DR.

J Immunol. 2005 Nov 15;175(10):6878-84.

3.

Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.

Gebhardt BM, Varnell ED, Kaufman HE.

J Ocul Pharmacol Ther. 2005 Apr;21(2):114-20.

PMID:
15857277
4.

Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.

Li W, Wang J, Jiang HR, Xu XL, Zhang J, Liu ML, Zhai LY.

Int J Mol Sci. 2011 Jan 18;12(1):668-81. doi: 10.3390/ijms12010668.

5.
6.

Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.

King VL, Trivedi DB, Gitlin JM, Loftin CD.

Arterioscler Thromb Vasc Biol. 2006 May;26(5):1137-43. Epub 2006 Mar 2.

7.

Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.

Okayama M, Hayashi S, Aoi Y, Nishio H, Kato S, Takeuchi K.

Dig Dis Sci. 2007 Sep;52(9):2095-103. Epub 2007 Apr 12.

PMID:
17429720
8.

Insights into inflammation and influenza.

Simmons C, Farrar J.

N Engl J Med. 2008 Oct 9;359(15):1621-3. doi: 10.1056/NEJMcibr0805865. No abstract available.

10.

Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats.

Noguchi M, Kimoto A, Sasamata M, Miyata K.

J Bone Miner Metab. 2008;26(5):461-8. doi: 10.1007/s00774-008-0855-3. Epub 2008 Aug 30.

PMID:
18758904
11.

[Mechanism of exacerbation of colonic damage in experimental colitis treated with celecoxib].

Zhang L, Lv Ym, Ye Sm, Dong Xy.

Beijing Da Xue Xue Bao. 2008 Apr;40(2):195-9. Chinese.

12.

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.

Cancer Res. 2000 Jan 15;60(2):293-7.

13.
14.

Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.

Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT.

Cancer. 2007 Feb 1;109(3):588-97.

15.

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.

Park W, Oh YT, Han JH, Pyo H.

J Exp Clin Cancer Res. 2008 Nov 11;27:66. doi: 10.1186/1756-9966-27-66.

16.

The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.

Lee IO, Seo Y.

Anesth Analg. 2008 Mar;106(3):972-7, table of contents. doi: 10.1213/ane.0b013e318163f602.

PMID:
18292448
17.

Effect of celecoxib on cyclooxygenase-1-mediated prostacyclin synthesis and endothelium-dependent contraction in mouse arteries.

Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D, Zhou Y.

Eur J Pharmacol. 2013 Jan 5;698(1-3):354-61. doi: 10.1016/j.ejphar.2012.10.040. Epub 2012 Nov 2.

PMID:
23127498
18.
19.

[Effect of cyclooxygenase-2 inhibitor on CD4+ CD25+ regulatory T cells in mouse hepatocellular carcinoma].

Xu DH, Chen L, Tang CW, Wang CH, Meng WT.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jul;44(4):545-9. Chinese.

PMID:
24059105
20.

Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.

Lu ZH, Xiong XY, Zhang BL, Lin GC, Shi YX, Liu ZG, Meng JR, Zhou YM, Mei QB.

Acta Pharmacol Sin. 2005 Dec;26(12):1505-11.

Supplemental Content

Support Center